Further mechanistic studies revealed that compound 6lc disrupts the SPOP-substrate protein interaction in ccRCC cell lines, leading to the stabilization and accumulation of tumor suppressors PTEN and DUSP7, while reducing the levels of phosphorylated AKT and ERK downstream 298. The gene discussed is PTEN; the disease is nonpapillary renal cell carcinoma.